The world's first self-amplifying mRNA vaccine, or replicon vaccine, was administered in Japan to prevent SARS-CoV-2 infection.1 Similar to other infodemics related to COVID-19 vaccines,2 ...

Given how serious the illness can be in certain populations, it’s important to make sure people are protected from getting RSV and have access to the vaccine through their insurance. Here’s what you ...

Dynavax Technologies Corporation's flagship product, Heplisav-B, continues to increase market share consistently in a growing ...

The world's first bivalent mRNA vaccine candidate against respiratory syncytial virus, or RSV, kicked off Phase I clinical ...

The Laredo Public Health Department announced the availability of 14 different vaccines which are available to the community.

Dynavax Technologies (NASDAQ: DVAX) Q3 2024 Earnings Call Nov 07, 2024, 4:30 p.m. ET ...